DNA 폴리메라아제 시장 규모, 점유율, 성장 분석 : 유형별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
DNA Polymerase Market Size, Share, and Growth Analysis, By Type (Taq Polymerase, Pfu Polymerase), By Application (Polymerase Chain Reaction, DNA Sequencing), By End-use, By Region - Industry Forecast 2025-2032
상품코드:1663064
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 DNA 폴리메라아제 시장 규모는 2023년에 1억 3,432만 달러로 평가되며, 2024년 1억 3,607만 달러에서 2032년에는 1억 5,088만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 1.3%로 성장할 전망입니다.
세계 DNA 중합효소 시장은 만성질환 증가, 유전자 연구의 발전, 맞춤형 의료에 대한 수요 증가에 힘입어 강력한 성장세를 보이고 있습니다. 암, 당뇨병, 심혈관 질환 등의 발병률이 증가함에 따라 복제, 증폭, 염기서열 분석에 DNA 중합효소의 필요성이 증가하고 있습니다. 이러한 효소는 유전자 변이 및 돌연변이를 식별하고 맞춤형 치료를 가능하게 하며 치료 결과를 개선하는 데 필수적입니다. 그러나 시장은 특수 효소의 높은 비용, 소규모 연구기관의 접근성 제한, 시장 진입을 복잡하게 만드는 치열한 경쟁과 엄격한 규제 준수 등의 장애물에 직면해 있습니다. 그럼에도 불구하고 기술 혁신과 R&D 투자 증가는 향후 수년간 DNA 중합효소 분야의 유망한 성장 전망을 시사하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 분석
특허 분석
DNA 폴리메라아제 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
Taq 폴리메라아제
Pfu 폴리메라아제
독자적인 효소 블렌드
기타
DNA 폴리메라아제 시장 규모 : 용도별 & CAGR(2025-2032)
시장 개요
중합효소 연쇄 반응
DNA 배열 해석
DNA 클로닝
기타
DNA 폴리메라아제 시장 규모 : 최종 용도별 & CAGR(2025-2032)
시장 개요
제약·바이오테크놀러지 기업
학술연구기관
병원과 진단 센터
기타
DNA 폴리메라아제 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Thermo Fisher Scientific Inc.(United States)
Hoffmann-La Roche AG(Switzerland)
Merck KGaA(Germany)
Qiagen N.V.(Netherlands)
Agilent Technologies Inc.(United States)
Takara Bio Inc.(Japan)
GenScript Biotech Corporation(United States)
Illumina Inc.(United States)
Promega Corporation(United States)
New England Biolabs, Inc.(United States)
Bioneer Corporation(South Korea)
Bio-Rad Laboratories, Inc.(United States)
Toyobo Co., Ltd.(Japan)
Bioline(United Kingdom)
Eurofins Genomics(Germany)
Integrated DNA Technologies(United States)
Twist Bioscience Corporation(United States)
ATUM(formerly DNA2.0)(United States)
Blue Heron Biotech(part of OriGene Technologies)(United States)
Bio Basic Inc.(Canada)
결론과 제안
KSA
영문 목차
영문목차
Global DNA Polymerase Market size was valued at USD 134.32 million in 2023 and is poised to grow from USD 136.07 million in 2024 to USD 150.88 million by 2032, growing at a CAGR of 1.3% during the forecast period (2025-2032).
The global DNA polymerase market is on a robust growth trajectory, fueled by rising chronic disease prevalence, advancements in genetic research, and the burgeoning demand for personalized medicine. As conditions like cancer, diabetes, and cardiovascular diseases escalate in incidence, the necessity for DNA polymerases in replication, amplification, and sequencing intensifies. These enzymes are essential for identifying genetic variations and mutations, enabling tailored therapies and enhancing treatment outcomes. However, the market faces hurdles such as high costs of specialized enzymes, potentially limiting access for smaller institutions, along with intense competition and stringent regulatory compliance that can complicate market entry. Nonetheless, technological innovations and increased R&D investments signal a promising growth outlook for the DNA polymerase sector in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dna Polymerase market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global DNA Polymerase Market Segments Analysis
Global DNA Polymerase Market is segmented by Type, Application, End-use and region. Based on Type, the market is segmented into Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends and Others. Based on Application, the market is segmented into Polymerase Chain Reaction, DNA Sequencing, DNA Cloning and Others. Based on End-use, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals & Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global DNA Polymerase Market
The global DNA polymerase market is being driven by the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, which has heightened the demand for advanced diagnostic and therapeutic technologies. Post-COVID, there has been a marked increase in the use of DNA polymerases, particularly high-fidelity variants that enhance the amplification processes in PCR. This surge is largely attributed to the urgent need for reliable and sensitive DNA replication methods to detect mutations accurately. To meet this demand, manufacturers are developing innovative DNA polymerase products that offer improved fidelity, speed, and performance, including specialized variants designed for amplifying and identifying disease-related DNA sequences.
Restraints in the Global DNA Polymerase Market
The escalating costs associated with DNA polymerases present a significant obstacle to the growth of the global DNA polymerase market, hindering the uptake of innovative technologies that depend on high-priced enzymes. Recent advancements in biotechnology have notably impacted the pricing dynamics of DNA polymerases, leading to a pronounced increase in costs. Consequently, numerous research laboratories and medical institutions may struggle to justify or afford these elevated expenses for polymerases, ultimately limiting their ability to implement cutting-edge techniques and innovations in their work. This financial barrier could slow down research progress and the integration of advanced molecular applications in various fields.
Market Trends of the Global DNA Polymerase Market
The global DNA polymerase market is witnessing notable growth driven by the increasing adoption of these enzymes in personalized medicine and targeted therapies. As the precision medicine paradigm continues to evolve, healthcare providers are leveraging DNA polymerases to identify specific genetic variations and mutations linked to various diseases. This trend facilitates the creation of customized treatments that enhance patient outcomes and optimize therapeutic efficacy. Additionally, rising investments in genetic research and advancements in biotechnology further propel the demand for DNA polymerases, positioning them as essential tools in the ongoing transformation of healthcare towards more individualized, effective treatment strategies.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis
Global DNA Polymerase Market Size by Type & CAGR (2025-2032)
Market Overview
Taq Polymerase
Pfu Polymerase
Proprietary Enzyme Blends
Others
Global DNA Polymerase Market Size by Application & CAGR (2025-2032)
Market Overview
Polymerase Chain Reaction
DNA Sequencing
DNA Cloning
Others
Global DNA Polymerase Market Size by End-use & CAGR (2025-2032)
Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals & Diagnostic Centers
Others
Global DNA Polymerase Market Size & CAGR (2025-2032)
North America (Type, Application, End-use)
US
Canada
Europe (Type, Application, End-use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Application, End-use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Application, End-use)
Brazil
Rest of Latin America
Middle East & Africa (Type, Application, End-use)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Thermo Fisher Scientific Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Hoffmann-La Roche AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Merck KGaA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Qiagen N.V. (Netherlands)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Agilent Technologies Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Takara Bio Inc. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
GenScript Biotech Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Illumina Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Promega Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
New England Biolabs, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bioneer Corporation (South Korea)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bio-Rad Laboratories, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Toyobo Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bioline (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Eurofins Genomics (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Integrated DNA Technologies (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Twist Bioscience Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
ATUM (formerly DNA2.0) (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Blue Heron Biotech (part of OriGene Technologies) (United States)